Davenport & Co’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Davenport & Co’s Portfolio GWPH Stock Details GWPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-2,045	Closed	-$236K	–	864
2020 Q4	$236K	Buy	+2,045	New	+$229K	﹤0.01%	705
2020 Q3	–	Sell	-1,881	Closed	-$231K	–	763
2020 Q2	$231K	Buy	+1,881	New	+$213K	﹤0.01%	612
2020 Q1	–	Sell	-3,327	Closed	-$348K	–	755
2019 Q4	$348K	Buy	+3,327	New	+$373K	﹤0.01%	555
2017 Q2	–	Sell	-2,541	Closed	-$284K	–	707
2017 Q1	$284K	Hold	2,541	–	–	﹤0.01%	502
2016 Q4	$283K	Buy	+2,541	New	+$306K	﹤0.01%	505

Other funds holding GWPH

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

GCL

Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return

EMG

ETF Managers Group Summit, New Jersey $3.1B AUM 17.12% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

UOC

UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Davenport & Co's GWPH Position: Q1 2021 in Review

Davenport & Co sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q1 2021, closing a stake of 2,045 shares — an estimated $236K sold.

Davenport & Co first reported a position in GWPH in Q4 2016 and held it in 5 quarters. The position peaked at $348K in Q4 2019. 297 funds tracked by Wall St. Rank hold GWPH as of Q1 2021.

Davenport & Co reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q1 2021 after selling out during the quarter.
Davenport & Co sold 2,045 GW Pharmaceuticals Plc American Depositary Shares shares in Q1 2021, an estimated $236K.
Davenport & Co first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q4 2016 and held it in 5 quarters.
Davenport & Co's GW Pharmaceuticals Plc American Depositary Shares position peaked at $348K in Q4 2019.
297 funds tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q1 2021.

Based on Davenport & Co's 13F filing for Q1 2021, filed 28 Apr 2021.